2022 Press Releases
-
Apr 2022
Benaroya Research Institute Awarded $11.4M NIH U19 Grant to Profile Respiratory Viral Infections in Vulnerable Populations and $3.9M NIH R01 Grant to Develop New Treatments for Type 1 Diabetes
-
Apr 2022
Benaroya Research Institute Team Examines COVID Vaccine Response in People Under Treatment for MS and Other Autoimmune Diseases
-
Mar 2022
Soo Jung Yang, PhD, Named Associate Member in the Center for Translational Research at Benaroya Research Institute
-
Jan 2022
BRI Research Team Links Down Syndrome, Aging and Autoimmunity
2021 Press Releases
-
Jun 2021
BRI President Jane Buckner, MD, Elected to FOCiS Leadership
-
Mar 2021
New Researcher Dr. Oliver Harrison at the Benaroya Research Institute at Virginia Mason Receives $2.9 Million NIH R01 Grant to Study How the Immune System Responds to the Microbiome
-
Feb 2021
New Study from the Benaroya Research Institute at Virginia Mason Finds "COVID-19 Immune Landscape Is Dynamically and Reversibly Correlated with Disease Severity"
-
Jan 2021
Kay Branz to Retire From Benaroya Research Institute at Virginia Mason
2020 Press Releases
-
Nov 2020
Thomas N. Wight, PhD, to Retire from Benaroya Research Institute at Virginia Mason
-
Sep 2020
Early introduction of gluten may prevent celiac disease in children
-
Aug 2020
Benaroya Research Institute at Virginia Mason Collaborates to Discover Genes that Block Viral Entry of Ebola and SARS Coronaviruses
-
Aug 2020
GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimmune and Inflammatory Diseases
-
Jul 2020
Dr. Carmen Mikacenic Joins Benaroya Research Institute at Virginia Mason
-
Jul 2020
Lynn Rose, PhD, to Retire from Benaroya Research Institute at Virginia Mason
-
Jul 2020
Benaroya Research Institute at Virginia Mason Announces More Than $5.8M in NIH Funding for COVID-19 Research
Apr 2022
Benaroya Research Institute Awarded $11.4M NIH U19 Grant to Profile Respiratory Viral Infections in Vulnerable Populations and $3.9M NIH R01 Grant to Develop New Treatments for Type 1 Diabetes
Apr 2022
Benaroya Research Institute Team Examines COVID Vaccine Response in People Under Treatment for MS and Other Autoimmune Diseases
Mar 2022
Soo Jung Yang, PhD, Named Associate Member in the Center for Translational Research at Benaroya Research Institute
Jan 2022
BRI Research Team Links Down Syndrome, Aging and Autoimmunity
-
Jun 2021
BRI President Jane Buckner, MD, Elected to FOCiS Leadership
-
Mar 2021
New Researcher Dr. Oliver Harrison at the Benaroya Research Institute at Virginia Mason Receives $2.9 Million NIH R01 Grant to Study How the Immune System Responds to the Microbiome
-
Feb 2021
New Study from the Benaroya Research Institute at Virginia Mason Finds "COVID-19 Immune Landscape Is Dynamically and Reversibly Correlated with Disease Severity"
-
Jan 2021
Kay Branz to Retire From Benaroya Research Institute at Virginia Mason
2020 Press Releases
-
Nov 2020
Thomas N. Wight, PhD, to Retire from Benaroya Research Institute at Virginia Mason
-
Sep 2020
Early introduction of gluten may prevent celiac disease in children
-
Aug 2020
Benaroya Research Institute at Virginia Mason Collaborates to Discover Genes that Block Viral Entry of Ebola and SARS Coronaviruses
-
Aug 2020
GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimmune and Inflammatory Diseases
-
Jul 2020
Dr. Carmen Mikacenic Joins Benaroya Research Institute at Virginia Mason
-
Jul 2020
Lynn Rose, PhD, to Retire from Benaroya Research Institute at Virginia Mason
-
Jul 2020
Benaroya Research Institute at Virginia Mason Announces More Than $5.8M in NIH Funding for COVID-19 Research
Nov 2020
Thomas N. Wight, PhD, to Retire from Benaroya Research Institute at Virginia Mason
Sep 2020
Early introduction of gluten may prevent celiac disease in children
Aug 2020
Benaroya Research Institute at Virginia Mason Collaborates to Discover Genes that Block Viral Entry of Ebola and SARS Coronaviruses
Aug 2020
GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimmune and Inflammatory Diseases
Jul 2020
Dr. Carmen Mikacenic Joins Benaroya Research Institute at Virginia Mason
Jul 2020
Lynn Rose, PhD, to Retire from Benaroya Research Institute at Virginia Mason
Jul 2020
